Supplementary Figures 1 - 6 from CHD7 Expression Predicts Survival Outcomes in Patients with Resected Pancreatic Cancer
Year: 2023
Type: supplementary-materials
Abstract: PDF file - 981KB, Representative Immunohistochemistry for CHD7 Expression in Primary Tumor Tissue (S1). Network Analysis via MetaCore ExPlain Process Network Analysis for genes involved in CHK1, CDC25A, AURKB, PLK1, HUS1 pathway (S2). CHD7 Knockdown Causes Gemcitabine Sensitization (S3). Mice with Xenograft Tumors Showed No Significant Difference in Body Weight (S4). CHD7 Knockdown Effect on Cell Cycle (S5). Gemcitabine Does Not Significantly Change CHD7 Protein Levels in Cells (S6).
Authors: Lauren E. Colbert, Aleksandra V. Petrova, Sarah B. Fisher, Brooke G. Pantazides, Matthew Z. Madden, Claire W. Hardy, Matthew D. Warren, Yunfeng Pan, Ganji P. Nagaraju, Elaine A. Liu, Burcu Saka, William A. Hall, Joseph W. Shelton, Khanjan Gandhi, Rini Pauly, Jeanne Kowalski, David A. Kooby, Bassel F. El-Rayes, Charles A. Staley, N. Volkan Adsay, Walter J. Curran, Jerome C. Landry, Shishir K. Maithel, David S. Yu
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: gold
OpenAlex ID: W4361873347